Back

The accumulation of orphan ribosomal proteins is a hallmark of ALS

Saez-Mas, A.; de la Vega-Barranco, G.; El-Manchoud, A.; Ventoso, I.; Rodrigo, S.; Lafarga, V.; Fernandez-Capetillo, O.

2026-05-19 neuroscience
10.64898/2026.05.18.725994 bioRxiv
Show abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of poor prognosis, for which age is the strongest risk factor. Despite significant progress in the discovery of ALS-associated mutations, no model explains how such a diversity of mutations converges in a common pathology. In addition, most ALS cases are sporadic and lack known genetic drivers. We recently reported that arginine-rich peptides arising from the C9ORF72 mutation trigger a widespread accumulation of orphan ribosomal proteins (oRP). Here, we show that oRP accumulation is also observed upon expression of other RNA-related ALS mutations, such as hnRNPA2D290V and TDP-43A315T, as well as upon exposure to the ALS-related neurotoxin {beta}-N-methylamino-L-alanine (BMAA). Furthermore, the transcriptional signature of patients with sporadic ALS resembles that of Diamond-Blackfan anemia (DBA), a known ribosomopathy. Supporting the usefulness of our in vitro data, a transcriptional signature defined from these models provides diagnostic and prognostic value in ALS patients. We propose that the accumulation of oRPs due to dysfunctional ribosome biogenesis is a molecular hallmark of ALS that can contribute to the progressive loss of motor neurons in the disease.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 9%
17.0%
2
EMBO Molecular Medicine
85 papers in training set
Top 0.1%
12.0%
3
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 6%
9.8%
4
eLife
5422 papers in training set
Top 12%
6.6%
5
Cell Reports
1338 papers in training set
Top 11%
4.7%
50% of probability mass above
6
Brain
154 papers in training set
Top 2%
3.8%
7
The EMBO Journal
267 papers in training set
Top 0.4%
3.5%
8
Acta Neuropathologica
51 papers in training set
Top 0.3%
3.5%
9
Science Advances
1098 papers in training set
Top 11%
2.5%
10
PLOS Biology
408 papers in training set
Top 8%
1.8%
11
Neuron
282 papers in training set
Top 6%
1.6%
12
Molecular Neurodegeneration
49 papers in training set
Top 0.5%
1.6%
13
Science Translational Medicine
111 papers in training set
Top 3%
1.6%
14
Molecular Therapy
71 papers in training set
Top 2%
1.6%
15
Cell Death & Differentiation
48 papers in training set
Top 0.3%
1.6%
16
Developmental Cell
168 papers in training set
Top 9%
1.6%
17
Journal of Experimental Medicine
106 papers in training set
Top 3%
1.3%
18
Cell Death & Disease
126 papers in training set
Top 2%
1.2%
19
Molecular Cell
308 papers in training set
Top 8%
1.2%
20
Nucleic Acids Research
1128 papers in training set
Top 14%
1.2%
21
Neurobiology of Disease
134 papers in training set
Top 3%
1.1%
22
Cell
370 papers in training set
Top 16%
0.9%
23
Nature Neuroscience
216 papers in training set
Top 6%
0.9%
24
Neuropathology and Applied Neurobiology
14 papers in training set
Top 0.7%
0.7%
25
Journal of Clinical Investigation
164 papers in training set
Top 7%
0.7%
26
EMBO Reports
88 papers in training set
Top 0.8%
0.7%
27
EMBO reports
136 papers in training set
Top 7%
0.7%
28
PLOS Genetics
756 papers in training set
Top 16%
0.7%
29
Advanced Science
249 papers in training set
Top 21%
0.7%
30
Immunity
58 papers in training set
Top 5%
0.7%